The Indian market for active pharmaceutical ingredients has experienced significant revenue generation.
The India Active Pharmaceutical Ingredients (API) market is expected to experience significant growth, with an estimated value of USD 14.81 billion in 2025 and a projected value of USD 25.23 billion by 2032, at a compound annual growth rate (CAGR) of 7.9%. This growth...
Cipla Limited and its division EMEU, have been honoured at the prestigious Healthcare Asia Pharma Awards 2025.
Cipla EMEU and Cipla Limited have been recognized at the Healthcare Asia Pharma Awards 2025 for their innovative initiatives. Cipla EMEU received the ESG Program of the Year - India award for its Ahead & Apart campaign, which promotes sustainable practices in the...
Sun Pharmaceuticals unveils its first-ever corporate brand initiative in the Indian market
Sun Pharmaceutical Industries (Sun Pharma) has launched a corporate brand campaign titled "Touching 1,000 Lives Every Minute" to highlight its role in supporting patients, caregivers, doctors, pharmacists, and communities. The campaign showcases the company's...
Emerging Trends and Investment Prospects in the Global Influenza Treatment Market
The Influenza Therapeutics Market report by Coherent Market Insights provides a comprehensive analysis of the market trends, drivers, challenges, and competitive landscape. The report is a valuable resource for industry leaders, investors, and decision-makers,...
Live Updates Q4 2025: Earnings reports expected today from key companies including Titan, L&T, Asian Paints, Britannia, Biocon, and more.
The fiscal fourth quarter earnings season is currently underway, with numerous large, mid, and small cap companies having already released their Q4 results. Major IT companies such as Tata Consultancy Services, Infosys, Wipro, and HCL Tech, as well as other prominent...
Apollo Cradle and Apollo One Join Forces in Electronic City, Marking a New Era in Comprehensive Family Healthcare Services
Apollo Cradle and Apollo One have joined forces to launch a state-of-the-art healthcare facility in Electronic City, a major hub for technology and innovation in India. This union marks a significant milestone in the realm of family healthcare, as two renowned...
Renowned Kennedy Advisor and Vocal Vaccine Skeptic Speaks Out Against Latest Expert Guidelines
A recent article has sparked controversy as a former aide to Senator Robert F. Kennedy Jr., who is also a vocal critic of vaccines, has questioned the latest expert recommendations on vaccination. The aide, who wishes to remain anonymous, has expressed concerns that...
Sun Pharma appoints Jayashree Satagopan as its new Chief Financial Officer
Sun Pharmaceutical Industries Ltd. is a prominent player in the Indian pharmaceutical industry. The company's product portfolio is diverse, with a focus on generic and over-the-counter (OTC) medicines, which account for approximately 94% of its net sales. These...
Sun Pharmaceuticals unveils its first-ever corporate brand initiative in the Indian market
Sun Pharmaceutical Industries (Sun Pharma) has launched a corporate brand campaign titled "Touching 1,000 Lives Every Minute" to highlight its role in supporting patients, caregivers, doctors, pharmacists, and communities. The campaign showcases the company's...
Sun Pharma appoints Jayashree Satagopan as its new Chief Financial Officer
Sun Pharmaceutical Industries Ltd. is a prominent player in the Indian pharmaceutical industry. The company's product portfolio is diverse, with a focus on generic and over-the-counter (OTC) medicines, which account for approximately 94% of its net sales. These...
Dilip Shanghvi’s fearless approach to risk has propelled Sun Pharma to great heights, and his entrepreneurial spirit shows no signs of slowing down.
Dilip Shanghvi, the 69-year-old chairman and managing director of Sun Pharma, India's largest pharmaceutical company, reflects on his 42-year journey of building the company from scratch. With a current market capitalization of ₹410,670 crore and a net cash position...
Sun Pharma’s MM-II trial demonstrates sustained pain relief for patients with knee osteoarthritis.
Sun Pharmaceutical Industries Ltd., India's largest pharmaceutical company, has announced promising results from a clinical trial for MM-II, a new non-opioid therapy for knee osteoarthritis pain relief. The trial, conducted in partnership with Moebius Medical,...
Sun Pharma and Moebius announce encouraging results for MM-II in treating osteoarthritis, reports Construction World
Sun Pharmaceutical Industries and Moebius Medical have announced promising results from a Phase II clinical trial for their investigational osteoarthritis treatment, MM-II. The study demonstrated significant improvements in pain reduction and functional improvement in...
Indian pharmaceutical companies Sun Pharma, Zydus, and Glenmark have issued recalls of their products in the US due to manufacturing concerns.
Three major Indian pharmaceutical companies, Sun Pharma, Zydus, and Glenmark, have issued recalls of their products in the United States due to manufacturing issues. The recalls were announced by the US Food and Drug Administration (FDA) and cover a range of products,...
Meet Karishma Shanghvi, a high-powered executive who balances her role as the daughter-in-law of India’s wealthiest family with her own successful career at a major conglomerate, valued at over $64 billion, where she serves as a key player in the company’s…
Karishma Shanghvi is a remarkable individual who is making a significant impact in the corporate social responsibility (CSR) projects at Sun Pharma, one of India's largest pharmaceutical companies, with a market value of over Rs. 4.5 lakh crore. As the daughter-in-law...
Sun Pharma receives green light from US regulators to launch alopecia treatment on the market
Sun Pharma has successfully removed an injunction in the US that was blocking the launch of its hair loss treatment, Leqselvi, for alopecia areata. The company had been facing a lawsuit from rival Incyte, which claimed that Leqselvi infringed on its patents for its...
SMA patients welcome Natco’s development of a generic drug, calling on the government to ensure timely access to it.
The article reports on the recent development of a generic drug by Natco Pharmaceuticals, a leading Indian pharmaceutical company, which is expected to benefit patients suffering from Spinal Muscular Atrophy (SMA). SMA is a genetic disorder that affects the muscles,...
Patents for Pharmaceuticals: Balancing Exclusive Rights with Public Welfare
The Indian court, Justice Mini Pushkarna, recently ruled against granting an injunction in favor of Roche, a pharmaceutical company, in a landmark case involving the patent dispute over the drug Risdiplam, used to treat Spinal Muscular Atrophy (SMA). The court's...
Natco Pharma’s Executive Vice President of Technology Transfer, Intellectual Property Rights and Regulatory Affairs, Dr Ramesh Dandala, retires.
A Senior Executive at Natco Pharma Retires Natco Pharma, a leading Indian pharmaceutical company, has announced the superannuation of Dr. Ramesh Dandala, the Executive Vice President of Technology Transfer, Intellectual Property Rights & Regulatory Affairs (API). Dr....
Citi cites low risk of US tariffs on Indian pharma, favoring Torrent Pharma and Divi’s.
Citibank has analyzed the potential impact of US tariffs on Indian pharmaceutical companies and has assigned a low probability to such an event. The brokerage firm simulated a 10% tariff scenario and found that companies with a high exposure to US generics, such as...
Delhi High Court orders Natco Pharma to put risk of launching novel spinal medication Risdiplam on hold in light of patent infringement controversy.
The Delhi High Court has ordered Natco Pharma to pause the launch of a generic version of Roche's rare disease drug, Risdiplam, amid a patent dispute. The court has restrained Natco Pharma from launching the generic version of the drug, which is used to treat spinal...
Delhi High Court grants Natco permission to manufacture and market Roche’s life-changing spinal muscular atrophy treatment
In a landmark ruling, the Delhi High Court has refused to grant an injunction to Roche, a pharmaceutical company, in a patent dispute over a cancer drug called Evrysdi (Risdiplam). The Court's decision was guided by precedent, citing a previous case where an...
Eli Lilly expands its global footprint by introducing Mounjaro, a groundbreaking weight management medication, to the Indian market.
Eli Lilly & Co. has launched its anti-obesity drug Mounjaro in India, making it the country's first treatment of its kind. The drug, which is used to treat obesity and type-2 diabetes, works by activating hormones that help reduce the amount of sugar in the blood and...
The Indian market for active pharmaceutical ingredients has experienced significant revenue generation.
The India Active Pharmaceutical Ingredients (API) market is expected to experience significant growth, with an estimated value of USD 14.81 billion in 2025 and a projected value of USD 25.23 billion by 2032, at a compound annual growth rate (CAGR) of 7.9%. This growth...
Cipla Limited and its division EMEU, have been honoured at the prestigious Healthcare Asia Pharma Awards 2025.
Cipla EMEU and Cipla Limited have been recognized at the Healthcare Asia Pharma Awards 2025 for their innovative initiatives. Cipla EMEU received the ESG Program of the Year - India award for its Ahead & Apart campaign, which promotes sustainable practices in the...
Sun Pharmaceuticals unveils its first-ever corporate brand initiative in the Indian market
Sun Pharmaceutical Industries (Sun Pharma) has launched a corporate brand campaign titled "Touching 1,000 Lives Every Minute" to highlight its role in supporting patients, caregivers, doctors, pharmacists, and communities. The campaign showcases the company's...
Emerging Trends and Investment Prospects in the Global Influenza Treatment Market
The Influenza Therapeutics Market report by Coherent Market Insights provides a comprehensive analysis of the market trends, drivers, challenges, and competitive landscape. The report is a valuable resource for industry leaders, investors, and decision-makers,...
Live Updates Q4 2025: Earnings reports expected today from key companies including Titan, L&T, Asian Paints, Britannia, Biocon, and more.
The fiscal fourth quarter earnings season is currently underway, with numerous large, mid, and small cap companies having already released their Q4 results. Major IT companies such as Tata Consultancy Services, Infosys, Wipro, and HCL Tech, as well as other prominent...
Apollo Cradle and Apollo One Join Forces in Electronic City, Marking a New Era in Comprehensive Family Healthcare Services
Apollo Cradle and Apollo One have joined forces to launch a state-of-the-art healthcare facility in Electronic City, a major hub for technology and innovation in India. This union marks a significant milestone in the realm of family healthcare, as two renowned...
Renowned Kennedy Advisor and Vocal Vaccine Skeptic Speaks Out Against Latest Expert Guidelines
A recent article has sparked controversy as a former aide to Senator Robert F. Kennedy Jr., who is also a vocal critic of vaccines, has questioned the latest expert recommendations on vaccination. The aide, who wishes to remain anonymous, has expressed concerns that...
Sun Pharma appoints Jayashree Satagopan as its new Chief Financial Officer
Sun Pharmaceutical Industries Ltd. is a prominent player in the Indian pharmaceutical industry. The company's product portfolio is diverse, with a focus on generic and over-the-counter (OTC) medicines, which account for approximately 94% of its net sales. These...
The Indian market for active pharmaceutical ingredients has experienced significant revenue generation.
The India Active Pharmaceutical Ingredients (API) market is expected to experience significant growth, with an estimated value of USD 14.81 billion in 2025 and a projected value of USD 25.23 billion by 2032, at a compound annual growth rate (CAGR) of 7.9%. This growth...
Cipla Limited and its division EMEU, have been honoured at the prestigious Healthcare Asia Pharma Awards 2025.
Cipla EMEU and Cipla Limited have been recognized at the Healthcare Asia Pharma Awards 2025 for their innovative initiatives. Cipla EMEU received the ESG Program of the Year - India award for its Ahead & Apart campaign, which promotes sustainable practices in the...
Cipla to Report Q4 FY 2025 Earnings on May 13, Dividend Payment Possible
Pharmaceutical company Cipla has announced the date for its earnings release for the fourth quarter and full year ended March 31, 2025. The company's Board of Directors is scheduled to meet on Tuesday, May 13, 2025, to consider and approve the standalone and...
A sudden surge in demand for Doxorubicin may send market momentum soaring, with influential companies like Merck & Co., Lupin, and Cipla playing a pivotal role.
The latest survey on the Doxorubicin market has been conducted to provide a comprehensive analysis of the market's performance, competitive environment, and market size. The report covers the period from 2019 to 2024 and provides a forecast till 2031. The market size...
Cipla Lacrosse up a massive partnership with Formosa, securing a sweeping deal spanning 11 countries for their clobetasol offerings.
Cipla, a leading global pharmaceutical company, has signed an exclusive licensing agreement to expand its ophthalmology portfolio and global offerings. The agreement involves the acquisition of Formosa Pharmaceuticals' US FDA-approved clobetasol propionate 0.05%...
Eli Lilly expands its global footprint by introducing Mounjaro, a groundbreaking weight management medication, to the Indian market.
Eli Lilly & Co. has launched its anti-obesity drug Mounjaro in India, making it the country's first treatment of its kind. The drug, which is used to treat obesity and type-2 diabetes, works by activating hormones that help reduce the amount of sugar in the blood and...
Apollo Cradle and Apollo One Join Forces in Electronic City, Marking a New Era in Comprehensive Family Healthcare Services
Apollo Cradle and Apollo One have joined forces to launch a state-of-the-art healthcare facility in Electronic City, a major hub for technology and innovation in India. This union marks a significant milestone in the realm of family healthcare, as two renowned...
Nabil Bank partners with Apollo Information Centre to provide customers with a 10% discount – Insurance Khabar
Nabil Bank Limited, a leading private sector bank in Nepal, has signed a Memorandum of Understanding (MoU) with Apollo Information Centre, the official representative organization of Apollo Hospitals in India. The agreement aims to provide special discounts and...
Hyderabad’s Apollo Hospitals successfully undertakes a rare tendon augmentation procedure, as reported by Telangana Today.
A groundbreaking surgical procedure was successfully performed by Dr. Prashant Meshram, a renowned shoulder surgeon, at Apollo Hospitals in Jubilee Hills, Hyderabad. The 58-year-old patient had been suffering from chronic pain and significant weakness in his right...
Aragonda Apollo Hospitals introduces state-of-the-art Uro Laser Technology Unit
Apollo Hospitals in Aragonda has introduced a state-of-the-art 'Uro Laser Technology Unit' to improve the diagnosis and treatment of kidney stones and other nephrological conditions. The launch of this unit demonstrates the hospital's dedication to providing...
Healthcare services of highest professional standards in Kolkata.
Healthcare Scan Diagnostics (HSD), a state-of-the-art diagnostic center in Kolkata, has partnered with Apollo Hospitals, Chennai to bring world-class healthcare expertise to patients in West Bengal. As part of this collaboration, renowned doctors from Apollo...
A doctor in Guwahati was arrested for allegedly sexually harassing a 14-year-old girl who is a friend’s daughter.
A cardiologist, Dr. Bikash Rai Das, has been arrested by the Dispur Police in Guwahati, India, for allegedly sexually harassing the minor daughter of his friend. The victim's mother lodged a complaint with the police, alleging that Dr. Das had committed the offense at...
Apollo Hospitals’ Health of the Nation 2025 Report Exposes Alarming Rise of Silent Chronic Diseases, Marking the Dawn of a New Era in Preventive Healthcare
The Apollo Hospitals Group has released its fifth edition of the Health of the Nation (HoN) 2025 report, highlighting a significant increase in preventive health checks, with over 2.5 million individuals screened in 2024, a 150% increase from 2019. The report...
Apollo Hospitals partners with Aamina Hospital, Nursing Home
Indraprastha Apollo Hospitals, a leading healthcare provider, has partnered with Aamina Hospital in Srinagar to bring world-class medical services to the region. As part of this collaboration, a team of 20 specialized doctors from various fields will provide...
GSK and Pfizer reach agreement to resolve patent dispute surrounding respiratory syncytial virus vaccine Arexvy
GlaxoSmithKline (GSK) has reached a global patent settlement with Pfizer, ending a lengthy legal battle over a breakthrough lung disease vaccine. The settlement allows Pfizer to have a worldwide license to certain GSK patents related to its respiratory syncytial virus...
The Global Drug Discovery Market Is Witnessing Exponential Growth From 2025 To 2032
The latest report by Coherent Market Insights on the Drug Discovery Market provides an in-depth analysis of the industry's trends, drivers, challenges, and competitive landscape from 2025 to 2032. The report offers a comprehensive segmentation of the market, covering...
Pfizer leverages artificial intelligence and automation to achieve an additional $1.2 billion in cost savings.
Pfizer has announced plans to leverage artificial intelligence (AI) and automation to generate an additional $1.2 billion in savings. This move is part of the pharmaceutical giant's ongoing efforts to improve operational efficiency and reduce costs. The company has...
Mark your calendars for April 24th: Pfizer to Host Virtual 2025 Annual Shareholders Meeting
Pfizer has announced that its 2025 Annual Meeting of Shareholders will be held virtually on Thursday, April 24, 2025, at 9:00 a.m. EDT. The company has designed the virtual meeting to provide shareholders with the same rights and opportunities to participate as they...
A raft of layoffs at Apple and Pfizer, potentially triggered by Trump’s tariffs, could have a subsequent impact on Europe’s pricey housing market, making it more affordable for would-be buyers.
The EU's economic growth may be impacted by impending layoffs among Apple and Pfizer employees, potentially softening one of Europe's most expensive housing markets. Trump's tariffs on tech goods could lead to economic disruption In response to Trump's 10% tariff on...
Esophageal Cancer Therapeutics Market Analysis 2024-2032: Key Players Include AstraZeneca, Takeda, Pfizer, Novartis, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi, AbbVie, and GlaxoSmithKline
The esophageal cancer market is expected to grow at a CAGR of 9% from 2024 to 2032, reaching a market value of USD 2.8 billion by 2032. The growth is driven by the increasing incidence of esophageal cancer, particularly in aging populations, and the need for advanced...
UC San Diego’s prestigious Moores Cancer Center receives a generous $1 million gift from Pfizer, furthering its mission to advance early cancer detection solutions.
The University of California, San Diego (UCSD) Moores Cancer Center has received a significant donation from Pfizer to launch an initiative focused on early detection and prevention of cancer. The partnership, which will be led by the Moores Cancer Center, aims to...
Are Gene Therapies Worth the Hefty Price Tag for a Chance at Success?
The article focuses on the latest development in the biopharma industry, specifically the exit of Pfizer from the market. According to the author, Andy Smith, the high price of treatments is the primary reason for Pfizer's departure. This comes as a surprise, as the...
Jackie Shroff Lends Support to Fortis’ ‘Red Run to End Thalassemia’ Awareness Campaign!
Bollywood actor Jackie Shroff has once again taken on the role of Brand Ambassador for a nationwide movement to eliminate Thalassemia from India by 2035. The initiative, #RedRuntoEndThalassemia, was launched by Fortis Memorial Research Institute, Gurugram, and aims to...
A 210-kg individual successfully undergoes robotic-assisted bariatric surgery at Fortis Hospital in Mohali.
A 210-kilogram man recently underwent a successful robot-aided bariatric surgery at Fortis Hospital in Mohali. The patient, who wishes to remain anonymous, was experiencing significant health complications due to his weight, including diabetes, high blood pressure,...
FMRI, Gurugram Introduces ‘Two-Minute Oral Cancer Prevention Initiative’
April is Oral Cancer Awareness Month, and to mark this occasion, Fortis Memorial Research Institute, Gurugram, has launched a campaign titled "Two-Minute Action for Oral Cancer Protection" under the hashtag #ActAgainstOralCancer. The campaign aims to address the...
Yemeni Woman, 63, Regains Mobility After 5-Year Struggle, Thanks to Successful Robot-Assisted Bilateral Knee Replacement Surgery at Fortis Bannerghatta – APN News
A 63-year-old woman from Yemen has successfully undergone a robot-assisted bilateral knee replacement surgery at Fortis Hospital, Bannerghatta, in Bengaluru, India. The surgery has enabled her to regain mobility after being bedridden for five years due to severe knee...
Fortis Hospital Mohali hosts symposium on colorectal cancer to encourage mass screening
Fortis Hospital Mohali recently organized a symposium on colorectal cancer, which drew over 130 delegates, including leading experts in the field of colorectal cancer surgery and oncology. The event aimed to educate healthcare professionals about the risk factors,...
Fortis Healthcare hosts a symposium to promote awareness about colorectal cancer prevention and treatment.
Fortis Cancer Institute in Mohali recently hosted a national symposium on colorectal cancer, aiming to raise awareness about the prevention and early detection of this preventable yet deadly disease. The event drew over 130 delegates, including leading oncologists and...
Fortis Hiranandani Hospital introduces the region’s first comprehensive blood disorder clinic, offering cutting-edge care for patients with blood-related conditions.
Fortis Hiranandani Hospital in Vashi, Navi Mumbai, has launched a dedicated Blood Disorder Clinic to provide comprehensive and patient-centered care for blood disorders, both cancerous and non-cancerous. The state-of-the-art clinic, led by Dr. Subhaprakash Sanyal,...
Fortis Hospital Vashi has opened a specialized blood disorder clinic.
Fortis Vashi, a hospital in Navi Mumbai, has launched a blood disorder clinic that offers a holistic treatment program for patients with blood disorders and related life-threatening conditions. The clinic is a subset of Fortis Institute of Blood Disorders and will...